初级肺高血压与II型骨形态蛋白质受体肺血管表达减少有关
Carl Atkinson1, Susan Stewart, Paul D Upton
1Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Cambridge, UK.
Circulation
|April 10, 2002
概括
肺部骨基因蛋白II型受体 (BMPR-II) 表达的减少与肺高血压有关. 这一发现表明BMPR-II在这种严重疾病特征的血管病变中起作用.
科学领域:
- 心血管研究研究心血管研究
- 肺部医学 肺部医学
- 分子生物学分子生物学
背景情况:
- 转化生长因子-β (TGF-β) 超级家族成员骨形态蛋白II型受体 (BMPR-II) 的突变与原发性肺高血压 (PPH) 有关.
- 在健康和患病的肺部中,BMPR-II的细胞表达部位在很大程度上仍然没有特征.
研究的目的:
- 为了研究BMPR-II在正常和肺高血压肺部的细胞局部.
- 为了将BMPR-II表达水平与BMPR2突变的存在和疾病严重程度相关联.
主要方法:
- 免疫组织化学用于检查PPH患者,二次肺高血压患者和健康捐赠者的肺组织中的BMPR-II表达.
- 在现场进行了杂交,以检测BMPR-II mRNA.
- 患者的基因型为BMPR2突变.
主要成果:
- 主要观察到BMPR-II表达在正常肺的血管内皮中.
- 在肺高血压中,BMPR-II染色有所变化,但包括内皮细胞和肌纤维细胞.
- 在PPH患者的外周肺部中,BMPR-II表达的显著减少被注意到,特别是那些BMPR2突变患者.
结论:
- BMPR-II的细胞分布支持其在PPH肺血管病变的发展中的作用.
- 减少BMPR-II表达可能会导致严重肺高血压中出现的血管消灭.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Pulmonary Edema II: Pathophysiology
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...


